These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22658258)

  • 1. Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up.
    Mäntyselkä P; Kautiainen H; Saltevo J; Würtz P; Soininen P; Kangas AJ; Ala-Korpela M; Vanhala M
    Atherosclerosis; 2012 Jul; 223(1):239-43. PubMed ID: 22658258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.
    Mäntyselkä P; Niskanen L; Kautiainen H; Saltevo J; Würtz P; Soininen P; Kangas AJ; Ala-Korpela M; Vanhala M
    Lipids Health Dis; 2014 Feb; 13():28. PubMed ID: 24507090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin level and lipoprotein particle size.
    Hämäläinen P; Saltevo J; Kautiainen H; Mäntyselkä P; Vanhala M
    Lipids Health Dis; 2018 Jan; 17(1):10. PubMed ID: 29321013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice weekly intake of farmed Atlantic salmon (Salmo salar) positively influences lipoprotein concentration and particle size in overweight men and women.
    Raatz SK; Johnson LK; Rosenberger TA; Picklo MJ
    Nutr Res; 2016 Sep; 36(9):899-906. PubMed ID: 27632909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.
    Magkos F; Mohammed BS; Mittendorfer B
    Int J Obes (Lond); 2008 Nov; 32(11):1655-64. PubMed ID: 18779822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents.
    Jago R; Drews KL; Otvos JD; Foster GD; Marcus MD; Buse JB; Mietus-Snyder M; Willi SM;
    J Pediatr; 2014 May; 164(5):1091-1098.e3. PubMed ID: 24508445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?
    Phillips CM; Perry IJ
    Atherosclerosis; 2015 Oct; 242(2):399-406. PubMed ID: 26277632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
    Freedman DS; Otvos JD; Jeyarajah EJ; Shalaurova I; Cupples LA; Parise H; D'Agostino RB; Wilson PW; Schaefer EJ
    Clin Chem; 2004 Jul; 50(7):1189-200. PubMed ID: 15107310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study.
    Choo J; Ueshima H; Curb JD; Shin C; Evans RW; El-Saed A; Kadowaki T; Okamura T; Nakata K; Otake T; Miura K; Abbott RD; Sutton-Tyrrell K; Edmundowicz D; Kuller LH; Sekikawa A;
    Am J Clin Nutr; 2010 May; 91(5):1195-203. PubMed ID: 20357040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions.
    Sarzynski MA; Burton J; Rankinen T; Blair SN; Church TS; Després JP; Hagberg JM; Landers-Ramos R; Leon AS; Mikus CR; Rao DC; Seip RL; Skinner JS; Slentz CA; Thompson PD; Wilund KR; Kraus WE; Bouchard C
    Atherosclerosis; 2015 Dec; 243(2):364-72. PubMed ID: 26520888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
    Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
    Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
    Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
    Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate.
    Yamashita S; Okazaki M; Okada T; Masuda D; Yokote K; Arai H; Araki E; Ishibashi S
    J Atheroscler Thromb; 2021 Sep; 28(9):974-996. PubMed ID: 33536398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ; Jenkins AJ; Zheng D; Lackland DT; McGee D; Garvey WT; Klein RL
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.